Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 20/20 | 0.75 |
| ▸ | PPARA | Q07869 | 14/20 | 0.75 |
| ▸ | PPARD | Q03181 | 3/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5099400 | 0.86 | PPARG (1.00) | PPARGPPARAPPARD | |
| SCHEMBL6985706 | 0.80 | PPARG (0.53) | PPARGPPARAPPARD | |
| SCHEMBL5103131 | 0.80 | PPARG (0.82) | PPARGPPARAPPARD | |
| SCHEMBL5210093 | 0.79 | PPARG (0.60) | PPARGPPARAPPARD | |
| SCHEMBL6989685 | 0.79 | PPARG (0.76) | PPARGPPARAPPARD | |
| SCHEMBL4092245 | 0.78 | PPARG (0.69) | PPARGPPARAPPARD | |
| SCHEMBL14431389 | 0.78 | PPARG (0.79) | PPARGPPARAPPARD | |
| SCHEMBL5105206 | 0.78 | PPARG (0.82) | PPARGPPARAPPARD | |
| SCHEMBL5222440 | 0.78 | PPARG (0.63) | PPARGPPARAPPARD | |
| SCHEMBL8258850 | 0.77 | PPARG (0.78) | PPARGPPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040097590-A1 | Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists | BROOKS DAWN ALISA (US) | 2004-05-20 | — | — | US | claimed |
| US-6930120-B2 | Oxazolyl-arylproplonic acid derivatives and their use as ppar agonists | ELI LILLY AND COMPANY (US) | 2005-08-16 | — | — | US | disclosed |
| US-20040097590-A1 | Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists | BROOKS DAWN ALISA (US) | 2004-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097590-A1 | Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists | PPARA, PPARG, PPARD | PPARG 2/4885PPARA 1/4885PPARD 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.